NASTAD Releases Module Two of the 2013 National AIDS Drug Assistance Program (ADAP) Monitoring Project Report

FOR IMMEDIATE RELEASE: April 2, 2013
Contact:
Meico Whitlock, 202-434-8094, www.NASTAD.org

ADAP Enrolling and Serving More Clients than Ever Before; Future Funding Uncertain

Download the 2013 National AIDS Drug Assistance Program (ADAP) Monitoring Project Annual Report (Module 2) (PDF)

Please contact Meico Whitlock (202-434-8094) for an interview about the report.

2013 NASTAD NAMP ReportWashington, DC – Today, the National Alliance of State and Territorial AIDS Directors (NASTAD) released the second and final module of its 2013 National ADAP Monitoring Project Annual Report. The National ADAP Monitoring Project is NASTAD’s long-standing effort to document new developments and challenges facing AIDS Drug Assistance Programs (ADAPs), assessing key trends over time and providing the latest available data on the status of ADAPs. For the last 18 years, NASTAD has provided comprehensive analysis about ADAPs through The Report.

Continue reading

Responding to Viral Hepatitis through Health Reform

By Oscar Mairena, Manager of Viral Hepatitis and Policy and Legislative Affairs, NASTAD

Oscar Mairena, Manager, Viral Hepatitis/Policy and Legislative Affairs, NASTAD

Oscar Mairena, Manager, Viral Hepatitis/Policy and Legislative Affairs, NASTAD

This weekend marks the third anniversary of the passage of the Patient Protection and Affordable Care Act (ACA). The ACA improves access to care and preventive services through expansion of public and private insurance, reforms that eliminate discriminatory insurance practices and make insurance coverage more affordable, and significant investments in prevention, care coordination, and health workforce and infrastructure. In the case of viral hepatitis, the ACA provides an opportunity to not only improve access to essential care and treatment for people living with viral hepatitis, but to diagnose viral hepatitis earlier and prevent new infections. In light of the ACA’s anniversary, NASTAD released a primer today on viral hepatitis and the ACA, The Affordable Care Act and the Silent Epidemic: Increasing the Viral Hepatitis Response through Health Reform. The primer provides an overview of how health reform impacts viral hepatitis prevention, screening, linkage and retention to care, and treatment.

Continue reading

Affordable Care Act (ACA) Celebrates Third Birthday: Many Successes, but Much Still To Do

By Amy Killelea, Senior Manager, Health Care Access, NASTAD

Signing of the ACAOn March 23, 2010 the Affordable Care Act (ACA) was signed into law. Three years later, many reforms are already helping people living with HIV and viral hepatitis access care and treatment:

  • AIDS Drug Assistance Program (ADAP) contributions now count toward Medicare Part D out-of-pocket spending, helping people living with HIV get through the coverage gap (“donut hole”) quicker.
  • Thousands of ADAP clients have been able to access insurance through Pre-existing Condition Insurance Plans (PCIPs).
  • Private insurance plans are now required to cover a range of preventive services (including services with a United States Preventive Services Task Force grade A or B as well as women’s preventive services) without cost sharing.
  • Several states have implemented the Medicaid Health Home program, which allows states to provide care coordination services – such as peer counseling, targeted social services referrals, and treatment management – for people with multiple chronic conditions, including HIV. Continue reading

National Women and Girls HIV/AIDS Awareness Day: Fighting HIV/AIDS through the Affordable Care Act

By Mildred Williamson, HIV/AIDS Section Chief, Illinois Department of Public Health and Amna Osman, Director, Division of Health, Wellness and Disease Control, Michigan Department of Community Health

Amna Osman, Director, Division of Health, Wellness and Disease Control, Michigan Department of Community Health

Amna Osman, Director, Division of Health, Wellness and Disease Control, Michigan Department of Community Health

Mildred Williamson, HIV/AIDS Section Chief, Illinois Department of Public Health

Mildred Williamson, HIV/AIDS Section Chief, Illinois Department of Public Health

National Women and Girls HIV/AIDS Awareness Day is a day to “Share Knowledge. Take Action.” As public health officials leading the fight against HIV and health inequities in our states, we recognize that the path to ending the HIV epidemic in the U.S. must include women and girls. So, today is a day to educate women and girls and their communities about the impact of HIV and offer a clarion call for us to take charge of our health. HIV/AIDS remains a serious public health challenge for women and girls. In 2009, women made up approximately a quarter of individuals living with HIV in the U.S. Furthermore, in 2009, African-American and Latina women accounted nearly three-fourths of new HIV infections among all women in the U.S. For African-American women and girls, the HIV infection rate in 2010 was 20 times that of White women and girls. As the backbone of our communities, women should share their stories and empower our girls and others around us. As said by the great poet Maya Angelou “There is no greater agony than bearing an untold story inside you.” Continue reading

Update: New Medicaid Essential Health Benefits Proposed Rule and What It Means for People Living with HIV and Hepatitis

By Amy Killelea, Senior Manager, Health Care Access, NASTAD

Amy Killelea, Senior Manager, Health Care Access, NASTADIn January, the Department of Health and Human Services (HHS) published a much-awaited proposed rule spelling out the “Essential Health Benefits” (EHB) requirements for newly eligible Medicaid beneficiaries (those ineligible for Medicaid under current Medicaid rules who will be eligible under the Affordable Care Act (ACA) in 2014 if states opt to expand). Comments may be submitted through the federal regulations website and are due February 21, 2013. The rule addressed a number of areas, the following of which will have a significant impact on people living with HIV and viral hepatitis: Continue reading